Brolucizumab-dbll Approved by FDA for Wet AMD
Injection for leading cause of severe vision loss and legal blindness.
FDA Approves Trifarotene Cream for Acne Treatment
First new treatment of its kind in over 20 years.
Physicians On-board with Herpes Zoster Vaccine
More doctors referring patients to pharmacies for shots.
Enteric Zoster: Hidden Shingles Threat
Characterized by severe abdominal pain.
FDA Approves Second HIV PrEP Treatment
Currently only approved for men and transgender women; future trials expected.
Studies Examining Marijuana and COPD
Whether marijuana use increases COPD susceptibility remains uncertain.
Flu Shot May Be a COPD Lifesaver
Only 50% of COPD patients are estimated to be vaccinated.
The 10 Best-and Worst-States for Vaccinations
Which states are the most likely to vaccinate-and which ones are most likely to skip?
Opinion: The Truth About ARCOS and the Opioid Epidemic
The DEA had access to information about where opioids were being sold, but didn’t act on it. Why?
NIH Awards $945 Million for Opioids Research
“Historic investment” distributed to private companies, universities, and researchers.
FDA, DEA Send Warning to Illegal Opioid Distributors
Controlled substance tramadol among the illegally marketed painkillers.
Biosimilars: Some Call for ‘Cautious Optimism’
Biosimilars may need more time to devleop in the market.
Rituximab Gains First Pediatric Approval
For granulomatosis with microscopic polyangiitis in children.
FDA Approves Canagliflozin Indication Expansion
Now approved for risk reductions in patients with type 2 diabetes mellitus.
Generics of Older Drugs Could Have Saved Medicare Billions, Study Says
Racemic substitutions for single-enantiomer drugs offer new opportunities for savings.
Biosimilars Need Access and Cost Examinations
Biologic medicines could lower spending by $153 billion by 2023.
USP Postponing Chapters 795, 797, and 825
Several pharmacy groups appealed guideline revisions.
The Latest Autoimmune Disease Treatment Advances
Psoriasis, MS, Lupus, and RA.
5 Pipeline Drugs to Watch
A look at some of the exciting drugs that could be approved in the coming months.
FDA Approves Jynneos for Smallpox and Monkeypox in Adults
Will be part of the U.S.’s public health emergency medical supplies and pharmaceuticals.
FDA Urged to Expedite Ranitidine Recalls
Online pharmacy that discovered the impurity discontinues sales.
Unique Offerings Increasing Revenue
Some pharmacies are now serving coffee and other refreshments.
Investigational Guillain-Barré Syndrome Treatment Granted FDA Fast Track Designation
Monoclonal antibody for autoimmune and neurodegenerative disorders.
The Growing Problem of Pharmacy Deserts
An estimated 100 million Americans lack good access to pharmacies.
What is a Pharmacy Desert?
Caused by lower income, insurance status, higher prices, poor transportation, long distances.
FDA Encourages OTC Naloxone and Expanded Access at Pharmacies
Approved forms should be considered as options for community distribution.
New Semaglutide Dosage Forms Approved by FDA
Now approved in 7mg and 14 mg tablets.
Patient Services are Crucial to the Economics of Pharmacy
Layoffs highlight increasing jobs problem.
A Look at USP 795, 797, and 800
Loyd Allen, Editor in Chief of the International Journal of Pharmaceutical Compounding, discusses the similarities and differences between three primary chapters of the USP professional practice standards.
The Difference Between 503a and 503b Compounding Pharmacies
Loyd Allen, Editor in Chief of the International Journal of Pharmaceutical Compounding, discusses the roles and limitations of each respective compounding classification.
